Sign inJoin waitlistJoin the waitlist

Jagadeesh Ramdas

Director · Geisinger Health System

Credentials: · · · ·

History

Geisinger Health System
Present

Pediatric Hematology Oncology
Louisiana State University School of Medicine
1998–2001
Pediatrics
Louisiana State University School of Medicine
1996–1998
All India Institute of Medical Sciences, New Delhi
1990–1994

Research

Effects of sodium thiosulfate versus observation on development of cisplatin-induced hearing loss in children with cancer (ACCL0431): a multicentre, randomised, controlled,…
The Lancet Oncology · 2017 · 226 citations
Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells
Cancer Research · 1999 · First of 3 authors · 95 citations
Glucocorticoid receptor gene mutations in leukemic cells acquired in vitro and in vivo
Cancer Research · 2000 · 56 citations

Andrea Seeley
2 papers
David Freyer
2 papers
Kristina Cole
2 papers
PT
Patrick Tomboc
2 papers
Scott Lindhorst
2 papers
Ben George
1 paper
BL
Beverly Lange
1 paper
CS
Conrad Schuerch
1 paper
Daniel Bowers
1 paper
DS
David Samuel
1 paper
Duncan Stearns
1 paper
EN
Edward Neuwelt
1 paper

Clinical trials

Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia
Site PI · Recruiting · Phase 3
Children's Oncology Group
2026–2033
Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2025–2028
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)
Site PI · Recruiting · Phase 3
Children's Oncology Group
2025–2031
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2024–2029